“…More recently, the MGIT 960 was evaluated for susceptibility testing of second-line drugs including levofloxacin, amikacin, capreomycin and ethionamide with overall agreement of 96% at critical concentrations when compared to the agar proportion method (Lin et al, 2009). Similar results were obtained in a study comparing the manual version of the MGIT to the agar method using the second-line drugs ofloxacin, kanamycin, ethionamide, and capreomycin (Martin et al, 2008). In both studies, the agreement between the two methods for ethionamide was markedly lower (86-88%) than for the other drugs (Martin et al, 2008;Lin et al, 2009).…”